tm logo
PATRYS
Live/Registered
SECTION 71 ACCEPTED

on 25 Apr 2019

Last Applicant/ Owned by

Level 4

South Melbourne

AU

VIC 3205

Serial Number

79046715 filed on 12th Jun 2007

Registration Number

3612574 registered on 28th Apr 2009

in the Principal Register

Correspondent Address

Mainak H. Mehta

Mainak H. Mehta

525 B. Street, Suite 2200,

San Diego, CA 92101

Filing Basis

No Filing Basis

Disclaimer

NO DATA

PATRYS

Pharmaceutical and biotechnological preparations and substances for human medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; [ veterinary preparations and substances for animal medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; ] diagnostic preparations for medical use and reagents for medical use, namely, for diagnosis of human disease Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical and biotechnological preparations and substances for human medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; [ veterinary preparations and substances for animal medicinal purposes, namely, for the treatment of cancers and autoimmune diseases; ] diagnostic preparations for medical use and reagents for medical use, namely, for diagnosis of human diseases, such as cancer and autoimmune diseases; [ pharmaceutical and biotechnological preparations, namely, antibodies for the treatment of cancers and autoimmune diseases; ] pharmaceutical and biotechnological preparations, namely, antibody fragments and antibody conjugates for the treatment of cancers and autoimmune diseases; [ pharmaceutical and biotechnological preparations for the reconstruction and repair of antibodies for use in the field of cancers and autoimmune diseases; ] monoclonal antibodies for medical and veterinary use, namely, reagents for the diagnosis and prognosis of human and animal diseases, such as cancer and autoimmune diseases; proteins for medical use, namely, for detecting antibodies; clinical medical reagents, namely, reagents for use in the development of monoclonal antibodies; proteins for medical use, namely, for binding antibodies; [ reagents for veterinary use, namely, reagents for the development of monoclonal antibodies; vaccines; vaccines against cancer, viral infection and bacterial infection, vaccines for human use; vaccine adjuvants; ] medical and veterinary diagnostic reagents, namely, reagents for use in tests for the diagnosis and prognosis of human and animal diseases, such as cancer and autoimmune diseases; reagents for research purposes, namely, diagnostic reagents for medical research applications; cells for medical or clinical use, namely, recombinant human protein production cell lines; proteins for medical use in the field of recombinant DNA technology; biological reagents for medical purposes in the field of molecular biology

Class [042]
Computer & Software Services & Scientific Services


Scientific research and development, clinical research and scientific advisory and consultancy services all in relation to antibody production; drug discovery; [ research and development of vaccines, namely, vaccine screening; ] scientific research advisory services relating to diagnostic products for diagnosing cancers and autoimmune diseases; [ diagnostic testing services, namely, providing reagent sample testing and diagnostic services for others in the field of science; ] medical research services; scientific research for medical purposes; pharmaceutical research services; scientific research advisory services comprising the preparation of reports relating to the performance and analysis of research and the outcomes of research in the field of pharmaceuticals and biotechnology; biochemical, chemical, microscopy, spectroscopy, physiological, histological, and electrical analysis of biological tissues for medical research; scientific research and development services for the production of antibodies; scientific research and development services for the discovery and development of proteins that bind to antibodies

Mark Details


Serial Number

No 79046715

Mark Type

No Service Mark

Attorney Docket Number

No 120776PLL001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Jan 2020INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
25th Dec 2019PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
25th Apr 2019REGISTERED-SEC.71 ACCEPTED
25th Apr 2019NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09th Apr 2019TEAS SECTION 71 RECEIVED
28th Apr 2018COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
29th Jun 2017INTERNATIONAL REGISTRATION RENEWED
01st Jul 2016NEW REPRESENTATIVE AT IB RECEIVED
11th Sep 2015PARTIAL INVALIDATION PROCESSED BY THE IB
19th Aug 2015INVALIDATION PROCESSED